Before Pankaj Jethwani was recruiting founders, he was learning what founding actually involved. The Breakfast Revolution, a social enterprise he co-founded in India, gave him a practical education in making a product, assembling a team, raising money and selling it. Before he entered Wharton, the enterprise had sold three million meals in two years. Breakfast, it turned out, came with a surprisingly extensive job description.
Years later, those same tasks sit at the centre of his work. Jethwani is chief executive of 2070 Health and managing partner at W Health Ventures. Together, the organisations build and finance companies in India and the United States. His particular interest is the period when a company is still mostly questions: who should lead it, what should it sell, and which assumptions deserve to survive contact with a customer?
The familiar startup story starts with a founder and an idea. Jethwani's studio can begin earlier, with a problem and a team doing research. The founder arrives as that work develops. It changes the opening scene of entrepreneurship. Someone has already begun checking the foundations before the new occupant picks out the curtains.
A founder before the business degree
His early enterprise matters because it puts the operating work ahead of the investment title. He had experienced product development, fundraising and sales before going to business school. The Breakfast Revolution remains part of his working life: he is its co-founder and a board member. It was an organisation he helped build, rather than a classroom exercise with a conveniently cooperative imaginary customer.
His career also took him through development-sector consulting and the public-sector practice of Boston Consulting Group. That sequence brought different kinds of organisations into view: a young enterprise trying to sell something, a consulting team working with institutions, and later an operating company in Boston, Iora Health. The jobs differed in their scale and responsibilities. Each involved getting people and resources to work together.
Jethwani earned an MBA at the Wharton School of the University of Pennsylvania, joining its class of 2018. Moving from India to an American business school added another setting to an already varied career. By then, he had work experience to bring into the classroom. A discussion about building a team could be measured against the difficulty of having actually done it.

Putting a workshop beside the fund
In 2022, Jethwani and entrepreneur Sunil Wadhwani started 2070 Health. Wadhwani became chairman; Jethwani became chief executive. Wadhwani brought a history of building technology businesses, including iGate. Their collaboration put a venture studio beside an investment organisation, giving the work of creating a company a home of its own.
A studio has to answer an awkward question that a cheque alone leaves open: who will do the work on Monday? At 2070, shared capabilities include talent, marketing, product and technology. Founders can draw on that team while shaping their own businesses. The arrangement makes the early organisation less dependent on one person discovering, in quick succession, that they also need to be a recruiter, marketer and product manager.
There is an ordinary attraction to this idea. Anyone who has assembled a team knows how much time disappears into the setup. A studio tries to preserve what it has learned from previous launches and make it available to the next founder. Whether that knowledge travels well is part of the continuing business challenge. Experience is useful; every new company still gets a vote.
The permission to abandon an idea
Jethwani has written about company creation with colleague Tushar Sadhu. Their 2023 essay treats product-market fit as a combination of market, idea, team and execution. The formula gives each component a place at the table. A persuasive concept cannot quietly excuse weak demand, and a capable team cannot make every market attractive through sheer good manners.
One detail in their account is particularly revealing. They describe studios typically discarding 90 percent of ideas before deploying equity capital. That is a statement about the process they advocate, rather than a published success rate for Jethwani's own portfolio. It gives rejection an active role. An abandoned concept can represent useful work if research has uncovered a reason to stop.
The appeal of that discipline is easy to understand. Once a business has a name, a team and a launch date, changing direction becomes an organisational event. Earlier, the same change can be a note in a research document. Jethwani's method gives those earlier decisions time and attention. The theatre of a launch is pleasant. Discovering a poor assumption while it is still inexpensive has its own quieter pleasures.
- 01InvestigateUnderstand the problem.
- 02ValidateTest demand with customers.
- 03RecruitFind the founding team.
- 04BuildWork alongside the founders.
A schematic of W Health Ventures' company creation process.
The founder search is part of the product
In describing 2070's approach in 2023, Jethwani placed substantial emphasis on matching the person to the opportunity. The studio looked for founders with experience of both starting and scaling, along with skills relevant to the particular business. Research could prepare the ground. A founder would still have to decide that this was where they wanted to spend their time.
The people around him give that principle names. Sanchit Mullick founded Reveal HealthTech after a career in technology products and services. Suryansh Kumar brought experience at consumer startups to Elevate Now. Nivesh Khandelwal and Vishwas Singh became founders of Nivaan Care. The roster reflects several routes into entrepreneurship rather than one preferred résumé.
Mullick has described weeks of conversations with the studio's talent team before joining. That is an instructive detail in a business often discussed through funding announcements. Company creation involves persuading a person to commit, allowing them to examine the arrangement, and finding out whether the interest lasts. An interview process can be a preview of the partnership that follows it.
A board seat comes with homework
Jethwani's responsibilities extend across organisations. Alongside the studio and fund, his responsibilities include board roles at companies including Wysa, Mylo, BeatO and Careforce. A board seat adds another relationship to his career: supporting a leadership team while also asking it difficult questions. The distance between encouragement and oversight can be shorter than a meeting agenda suggests.
Asked about startup governance in 2023, he recommended financial and legal audits, checks for conflicts of interest and regular monitoring that includes cash flows. He also described how boards should develop committees as companies grow. It is a practical set of concerns, and an unglamorous one. Cash has a habit of behaving independently of the elegance of a presentation.
His network includes people whose experience predates the studio. When Ashish Singh joined W Health Ventures as an operating partner, Jethwani publicly thanked him for years of mentorship. That acknowledgement complicates the usual portrait of an investor dispensing advice. He also receives it. The organisation's team and advisory roster put experienced operators and specialists alongside its investment work.
From Boston to India, with work in both directions
Boston is Jethwani's base, while 2070's company-building work has roots in India. W Health Ventures lists offices in Boston, Mumbai, Delhi and Bengaluru. His career connects these places through study, operating experience and investment responsibilities. It is a geography of working relationships, with different teams bringing different knowledge to the same discussion.
He has argued that Indian founders serving American customers can compete through quality, insight and speed, as well as cost. That distinction matters to the kind of companies he wants to help build. It asks founders to think about what they contribute to a customer's business, and how that contribution will be recognised. A lower price may open a conversation; the work has to sustain it.
His own route gives this argument a personal context. He has worked inside organisations on both sides of that corridor. The practical challenge for a company operating across borders is to make the connection useful: to turn access to people, knowledge and customers into something a team can repeatedly deliver. Geography supplies the opportunity. Execution supplies the receipt.
₹700 crore, and a deliberately small list
In September 2026, W Health Ventures closed its second fund at ₹700 crore, above its original ₹630 crore target. The plan was to build eight to ten companies over four years. For Jethwani, the announcement extended the company creation approach with a new pool of capital and a defined group of businesses to develop.
The modest length of that company list is central to understanding the undertaking. Building alongside founders requires attention that cannot be multiplied as easily as a spreadsheet row. Each additional business brings hiring, product decisions and operating questions. The fund's scale therefore has to be read together with its intended workload. These are plans for future creation, with the future results still ahead.
A summer with consequences
There is a smaller annual undertaking that brings Jethwani's career back to learning. W Health Ventures and 2070 host two to four pre-MBA interns each year. He describes it as rewarding work. The participants help develop ventures, investigate opportunities and support portfolio companies. They also sit in founder meetings, where decisions have consequences beyond completing an assignment.
“There are rarely clean answers.”
Pankaj Jethwani, on the pre-MBA internship programme
That sentence is an appealingly candid prospectus. A summer before business school could offer a tidy introduction to the vocabulary of investing. Here, Jethwani promises ambiguity alongside responsibility. Alumni of the programme have gone on to Wharton, Harvard, Yale and Darden. The relationships, he says, often continue after the summer ends.
It is a fitting place to leave him: still assembling a team, still making room for people to learn by working. His early experience brought product development, fundraising and sales into the same job. His current organisations try to give founders help with that crowded brief. The questions have grown larger, and the capital has grown with them. Someone still has to work out what happens on Monday.